Pfizer, Allergan CEOs: Tie-up aims for growth, not cost cuts

TRENTON, N.J. — The heads of drugmakers Pfizer and Allergan said Tuesday that the record $160 billion combination they’re planning is meant to produce more medicines and boost revenue, not to just slash jobs and other costs as the companies previously have done. The deal announced last November would move Pfizer’s official headquarters for tax […]